Quidel

News Release

Printer Friendly Version View printer-friendly version
<< Back
Lin Haelewyn Promoted to Senior Vice President, And Appointed an Officer of Quidel Corporation

SAN DIEGO, June 9 /PRNewswire/ -- Quidel Corporation (Nasdaq: QDEL) today announced the promotion of Linda (Lin) Haelewyn to the position of Senior Vice President, Global Commercial Operations. The Board of Directors has also appointed Lin an Officer of Quidel Corporation. Ms. Haelewyn will be responsible for the development and implementation of Quidel's marketing and sales worldwide.

"This promotion is richly deserved since, in a relatively short tenure with Quidel, Ms. Haelewyn has established herself as an important corporate leader and contributor to our recent successes," said Andre de Bruin, President & Chief Executive Officer.

After joining Quidel Corporation in August 1999 to launch new initiatives and increase product sales, by October Ms. Haelewyn was promoted to Vice President, Commercial Operations, overseeing global marketing and sales.

Ms. Haelewyn brings over 22 years of cross-functional experience in domestic and international sales and marketing in the medical diagnostics industry.

Prior to joining Quidel Corporation, Ms. Haelewyn was Vice President, Global Marketing and Support Services, for Nichols Institute Diagnostics (NID) where she directed and managed a global staff of 65 plus people and was responsible for universal marketing, communications, technical services, sales, customer training, field service and business development. She also spent many years in management positions at Boehringer Mannheim Corporation before NID, during which time she developed, coordinated and launched product commercialization strategies both internationally and domestically.

Ms. Haelewyn is an ASCP Board Registered Medical Technologist and serves as an active member of local and national biomedical associations. Linda lives with her husband, Earl, and resides in Rancho Santa Fe, California.

Quidel is a market leader in point-of-care, rapid diagnostics, providing simple, accurate and cost-effective diagnostic tests to physicians and/or consumers. QDEL's Test and Treat products are easy to use and provide results in minutes, facilitating rapid treatment and improve health outcomes, lower costs, and increase patient satisfaction. Its core products address issues relating to a woman's health throughout her life including reproductive status, pregnancy management and osteoporosis. In addition, the Company provides diagnostic products for all family members for common health problems and infectious diseases, including influenza A and B, strep throat, H. pylori infection, chlamydia and infectious mononucleosis. Quidel's products are sold to healthcare professionals for use in physicians' offices, clinical laboratories, pharmacies, and wellness screening centers. Quidel also manufactures a line of products sold to consumers through organizations that provide store branded products.

CONTACT:
Linda Haelewyn, Senior Vice President, Global Commercial Operations, 858-552-7964,
or Margaret Kuhn, Director, Investor Relations and Corporate Communications, 858-646-8031,
both of Quidel Corporation